Author Question: Which of the following would you initially verify in assessing the airway of a patient placed on ... (Read 42 times)

panfilo

  • Hero Member
  • *****
  • Posts: 572
Which of the following would you initially verify in assessing the airway of a patient placed on ventilatory support? 1. Cuff pressure 2. Tube position 3. Tube patency
 
  a. 1 and 2 only
  b. 1, 2, and 3
  c. 1 and 3 only
  d. 2 and 3 only

Question 2

When setting the tidal volume on a patient being mechanically ventilated, what criteria should be kept in mind?
 
  a. It should never cause the plateau pressure to exceed 28 mm Hg.
  b. It should never cause the peak pressure to exceed 35 mm Hg.
  c. It should result in the static pressure of less than 10 mm Hg.
  d. It should result in a peak pressure of no more than 25 mm Hg.



zogaridan

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

ANS: B
The artificial airway should be assessed for proper placement, patency, and cuff inflation. Size, position, and depth of the endotracheal tube and cuff pressure, including volume used to inflate the cuff, should be recorded.

Answer to Question 2

ANS: A
Tidal volume usually is based on specific patient considerations but should ideally never result in a plateau pressure of 28 cm H2O or greater.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The immune system needs 9.5 hours of sleep in total darkness to recharge completely.

Did you know?

Vaccines cause herd immunity. If the majority of people in a community have been vaccinated against a disease, an unvaccinated person is less likely to get the disease since others are less likely to become sick from it and spread the disease.

Did you know?

Essential fatty acids have been shown to be effective against ulcers, asthma, dental cavities, and skin disorders such as acne.

Did you know?

On average, the stomach produces 2 L of hydrochloric acid per day.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library